Table 6.
Summary of the potential therapeutic target miRs in laryngeal cancer
| MiRs | Deregulation | Molecular mechanisms | Ref |
|---|---|---|---|
| miR-1 | Downregulation | Suppresses the migration and invasion of LSCC cells by targeting fibronectin1 | [63] |
| miR-129-5p | Downregulation | Inhibits growth and induces apoptosis in LSCC by directly targeting APC and possibly modulating STAT3 | [41,64] |
| miR-155 | Upregulation | Enhances proliferation and invasion of human laryngeal squamous cell carcinoma via targeting SOCS1 and STAT3 | [37] |
| miR-206 | Downregulation | Promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression | [65] |
| miR-24 | Downregulation | Functions as a tumor suppressor in laryngeal carcinoma partly through downregulation of the S100A8 protein | [66] |
| miR-30b | Downregulation | Improves the anti-tumor effect of p53-mediated gene therapy | [68] |
| miR-31-star, miR-1264, miR-3150b-5p and miR-210 | Significantly expression altered | Their expressions are significantly changed after paclitaxel treatment | [67] |
| miR-93 | Upregulation | Promotes LSCC cell proliferation, migration and invasion by directly targeting cyclin G2 | [69] |